CannabisNewsBreaks

WednesdayJul 17, 2024 3:10 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Noteworthy Findings from Interim Results of Ongoing Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the receipt of interim results from the first four weeks of dosing in its ongoing diabetes animal study WEIGHT-A24-1. The company noted that the results have already produced several noteworthy findings. According to the announcement, unlimited food and water have been provided to the animals for the entire duration of the study. During the initial acclimation phase, which spanned 34 days before the beginning of dosing, the animals gained 10.9% body weight on average. During the subsequent 28 days of DehydraTECH-processed drug therapy dosing, all test…

Continue Reading

TuesdayJul 16, 2024 1:31 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Makes Management Announcement, Plans for Strategic Growth

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is preparing for growth by executing a strategic growth plan. A key element of the plan includes expanding the company’s management team to enable efficient handling of a greater workload of projects and initiatives. With that in mind, the company has named Nelson Cabatuan as consulting chief strategic financial advisor; Cabatuan is currently serving as Lexaria CFO. In his new role, Cabatuan will leverage his skills in corporate finance and strategic industry relationships to focus on strategic opportunities. In addition, Lexaria is working on other research and development projects…

Continue Reading

FridayJul 12, 2024 3:30 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) Ideally Positioned as DEA’s Move to Reclassify Cannabis Signals New Era

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) noted a historic milestone as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. “The company released an announcement from CEO Jose Gabriel Diaz and observed that the ‘monumental decision,’ based on recommendations from the U.S. Department of Health and Human Services, signifies a significant shift in U.S. drug policy… While there may be work left to do, the initial rescheduling is certainly noteworthy. The announcement from MedCana noted that cannabis has been unjustly categorized as a Schedule I substance alongside…

Continue Reading

ThursdayJul 11, 2024 10:34 am

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Hails ABI Create’s ‘Stellar Reputation and Proven Track Record’ Amid Plans to Make Destino Ranch a World-Class Destination

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today provided an update on ABI Create’s legacy and vision for the future. ABI Create is a division within Lavish Entertainment, a wholly owned subsidiary of Golden Triangle Ventures. Founded in 2015 by Marco Antonio Moreno, ABI Create has earned a reputation for delivering top-quality productions at major events across the United States. ABI Create offers an all-in-one approach, making it a preferred partner for large-scale productions with a comprehensive suite of services, including event organization, management, production, logistics, site planning and permit consulting, construction, contracting, custom design, and fabrication. According…

Continue Reading

TuesdayJul 09, 2024 3:16 pm

CannabisNewsBreaks – CannaCon Event to Propel Networking, Knowledge Exchange in Fast-Growing Sector

CannaCon, a premier conference company that produces state-of-the-art B2B events for cannabis businesses, marijuana entrepreneurs, investors, and community partners to showcase industry products, people, innovations, and technology, today announced plans to host the 5th CannaCon Midwest St.Paul on Aug. 16-17, 2024. The event, designed to drive growth of the cannabis industry in both the Midwest and nationally while creating lasting value for the sector through high-powered networking and knowledge exchange, is slated to take place at the iconic Saint Paul River Center in St. Paul, Minnesota. Like-minded entrepreneurs and industry professionals will convene for the event with a mission to…

Continue Reading

TuesdayJul 09, 2024 2:29 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Second GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that human pilot study #2, GLP-1-H24-2, has now completed all dosing. The final DehydraTECH study arm used a Rybelsus(R) composition processed with DehydraTECH that is compliant with the FDA’s Inactive Ingredient Database (“FDA IID”), delivered within an in-mouth dissolvable tablet. According to the announcement, this will be the first study designed to investigate whether DehydraTECH-enhanced semaglutide can absorb at any level systemically through the sublingual/buccal tissues of the mouth and throat with fewer side effects than from swallowed administration, and with some effective drug delivery into…

Continue Reading

MondayJul 01, 2024 3:45 pm

CannabisNewsBreaks – Golden Triangle Ventures Inc.’s (GTVH) Lavish Moves to Become Staple in the Entertainment Industry

Golden Triangle Ventures’ (OTC: GTVH) Lavish Entertainment embodies GTVH’s focus on vertical integration to cut costs and maximize margins, as evidenced by its recently released four-pillar business model. “According to GTVH, this strategic framework provides an essential piece of Lavish’s mission to create an industry leading entertainment business. The company’s new model includes key foundational elements – logistics, staffing, equipment and production – that were carefully identified and organized to complement each other and ensure seamless operations across all facets of the company. With its new business model as a backdrop, Lavish Entertainment plans to develop and acquire operations in…

Continue Reading

ThursdayJun 27, 2024 3:30 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Favorable Strategic Partnering with Leading GLP-1 Players

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked to diabetes… The company recently received independent third-party ethics review board approval for its GLP-1 human pilot study #2, seeking to explore the oral delivery of GLP-1 drugs. For Lexaria, this marks a significant milestone that brings it closer to offering a more effective and…

Continue Reading

ThursdayJun 27, 2024 3:00 pm

CannabisNewsBreaks – Software Effective Solutions Corp.’s (SFWJ) Eko2o at Forefront of Innovation

Software Effective Solutions’ (OTC: SFWJ) subsidiary, Eko2o S.A.S., has solidified its reputation as a leading provider of greenhouse infrastructure and agricultural technology. “Eko2o is experiencing significant growth and success, as evidenced by recent news that it has become a key infrastructure supplier for some of Colombia’s largest flower producers. In addition, Eko2o is strengthening its support and sales operations through international partnerships and collaborations, including with Danzinger International… Eko2o’s commitment to excellence and innovation continues to attract the attention of major industry players, contributing to Colombia’s reputation as a leader in floriculture and agricultural technology. The company is at the…

Continue Reading

WednesdayJun 26, 2024 1:15 pm

CannabisNewsBreaks – GRN Holding Corp. (GRNF) Rebranding with Marijuana Icon Leading at Helm

GRN Holding (OTC: GRNF), a publicly quoted company focused on the global distribution and sale of marijuana in jurisdictions where it is legal, is in the process of a strategic rebranding initiative; the company is rebranding to Marijuana Inc. According to the announcement, the rebranding strategy represents “a new era of growth and innovation in the global cannabis industry.” This transformation is being led by Donald Steinberg, who has been involved in the marijuana space for more than 50 years and has been called the “Henry Ford of the marijuana industry.” Steinberg’s contributions to the world of marijuana have been well…

Continue Reading